BioSpace News Archive

Business

SmartLabs Announces Biopharma Veteran Brian Taylor as New Interim CEO

SmartLabs, Inc. today announced that Brian Taylor has been appointed interim Chief Executive Officer effective January 5th.

January 11, 2024
·
2 min read
Biotech Bay

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium

Mainz Biomed N.V. re-affirms its collaboration with TestDNA at the upcoming 10th Gdańsk Gastroenterology Symposium on January 12th–13th, 2024.

January 11, 2024
·
5 min read
Deals

TransCode Therapeutics Announces 1-for-40 Reverse Stock Split

TransCode Therapeutics, Inc. today announced that its Board of Directors has approved a 1-for-40 reverse stock split, to be effective at 12:01 a.m. Eastern Standard Time Tuesday, January 16, 2024.

January 11, 2024
·
4 min read
DecisionRx Announces $100 Million Credit Facility with Carlyle

DecisionRx, Inc. today announced that it has entered into a $100 million credit facility with global investment firm Carlyle.

January 11, 2024
·
4 min read
Biotech Bay

Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency

Veeva Systems announced that SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co. Ltd., a global biotech company, is using Veeva Vault Validation Management to streamline and accelerate their validation process.

January 11, 2024
·
3 min read
Press Releases

QIAGEN N.V. to release results for Q4 2023 and hold webcast

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the fourth quarter and full year 2023.

January 11, 2024
·
1 min read
Business

DNAnexus and Intelliseq Combine Efforts to Add Automated Genomic Variant Interpretation and Clinical Reporting Capabilities to Precision Health Data Cloud

DNAnexus, Inc. today announced a partnership to simplify and accelerate variant interpretation and clinical reporting.

January 11, 2024
·
3 min read
Business

Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Pr. Xavier Declèves

VECT-HORUS today announced the appointment Pr. Xavier Declèves to its scientific advisory board (SAB).

January 11, 2024
·
2 min read
The European Medicines Agency’s Scientific Advisory Group (SAG) to discuss the Marketing Authorisation Application for lecanemab: BioArctic

BioArctic AB’s partner Eisai announced that the Scientific Advisory Group will convene to discuss the Marketing Authorisation Application of lecanemab, which is currently under review by the European Medicines Agency.

January 11, 2024
·
6 min read
SyntheticGestalt and Enamine to Collaborate on the Creation of AI-Based Model to Facilitate Drug Discovery

SyntheticGestalt and Enamine have announced the start of a joint effort to create a suite of AI models that will enable the generation of synthetically accessible biologically active compounds with optimized physicochemical and ADME/ Tox properties.

January 11, 2024
·
4 min read